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Abstract: European students (n = 370), academics (n = 241) and community pharmacists (n = 258)
ranked 13 clusters of 68 personal and patient care competences for pharmacy practice. The results
show that ranking profiles for all three groups as a rule were similar. This was especially true of the
comparison between students and community pharmacists concerning patient care competences
suggesting that students have a good idea of their future profession. A comparison of first and fifth
(final) year students shows more awareness of patient care competences in the final year students.
Differences do exist, however, between students and community pharmacists. Students—like
academics—ranked competences concerned with industrial pharmacy and the quality aspects of
preparing drugs, as well as scientific fundamentals of pharmacy practice, well above the rankings of
community pharmacists. There were no substantial differences amongst rankings of students from
different countries although some countries have more “medicinal” courses than others. This is to our
knowledge the first paper to look at how, within a healthcare sectoral profession such as pharmacy,
the views on the relative importance of different competences for practice of those educating the
future professionals and their students, are compared to the views of working professionals.
Pharmacy 2016, 4, 8; doi:10.3390/pharmacy4010008 www.mdpi.com/journal/pharmacy
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1. Introduction
The PHARMINE (Pharmacy education in Europe) [1] study aimed at promoting the use of
competence frameworks in European pharmacy education. Competence frameworks have been
developed to facilitate practitioner development and assessment, and have already been used in the
workplace to monitor and improve practice of Singaporean hospital pharmacists [2], and of hospital
pharmacists in Queensland [3]. Studies have also been conducted in the UK [4] and in Canada [5] in
community pharmacy. These studies attempted to define the roles of pharmacists in a community
or hospital setting and establish measurable outcomes on the possible impact of the application of
competence frameworks for development and assessment. All studies concluded that competence
frameworks are useful tools to monitor and improve performance in the workplace. PHARMINE and
its follow-up project PHAR-QA (Quality Assurance in European Pharmacy Education and Training) [6]
extended this approach to pharmacy education. A competence framework similar to that used in the
four studies cited previously was used. The main difference between the two was, that with the four
studies done in the workplace, the emphasis was on the fourth level of Miller’s triangle i.e., “does”
whereas in this study emphasis was one the first two levels “knows” and “knows how” (see conclusions).
Thus the studies in the workplace are aimed at personal development and improvement in action
whereas this study is aimed more at adapting pharmacy education to a competence approach. These
aspects will be taken up in the discussion following the exposé of the study and results.
The PHAR-QA (“Quality Assurance in European PHARmacy Education and Training”) project,
funded by the European Commission, asked pharmacy students, academics, and community
pharmacists to rank competences for pharmacy practice.
This paper asks the question of whether the ranking of competences by students is similar to
that of academics and/or to that of community pharmacists. It also looks at whether their ideas on
the relative ranking of competences evolve during their studies by comparing the scores of first year
students with that of fifth (final) year students. Finally, it also looks at potential differences amongst
students from different countries.
The methodology used is based on that in the MEDINE (“Medical Education in Europe”) project
that asked medical doctors and students to rank competences for the medical practitioner [7].
2. Experimental Section
Ranking data on competences for practice were obtained via the PHAR-QA surveymonkey [8]
questionnaire that was available online from 14 February 2014 through 1 November 2014 i.e., 8.5
month [9]. Respondents came from 33/38 (Table 1) countries drawn from the European Higher
Education Area [10].
Table 1. Student respondents by country.
The number of students who responded from each country.
Germany 127
Czech Republic 32
Portugal 28
Romania 21
Belgium 20
Finland 18
Macedonia (FYROM) 12
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Table 1. Cont.
The number of students who responded from each country.
Croatia 10
Malta 10
France 7
Latvia 7
Montenegro 7
Estonia 6
Greece 6
Poland 6
Slovenia 6
Spain 6
Norway 5
The Netherlands 5
Turkey 5
UK 4
Serbia 3
Switzerland 3
Austria 2
Denmark 2
Sweden 2
Ukraine 2
Albania 1
Bosnia 1
Hungary 1
Kosovo 1
Lithuania 1
Slovakia 1
Belarus 0
Bulgaria 0
Iceland 0
Ireland 0
Italy 0
Nine countries were represented by 10 or more respondents, 21 countries by four or more, five
countries had no respondents. Two respondents did not answer the “country of residence” question.
The questionnaire was distributed by several means. Firstly the PHAR-QA consortium nominated four
regional managers (north, south, east, and west) who sent out the survey to the various countries based
on their geographical location in Europe. The regional managers contacted pharmacy departments,
students and organizations representing other groups, chambers, governments and other agencies.
The survey was also distributed by the European Pharmacy Students’ Association via its national
representatives. Thus the survey was distributed randomly and anonymously. No attempt was made
to target specific groups to obtain a previously established number of respondents, as a function, for
example, of the population of the country. Our approach produced an imbalanced distribution across
European countries with small countries such as Malta in the top nine for respondents and large
countries such as Italy having no student respondents. Furthermore no attempt was made to have an
equal number of respondents for the three groups (students, academics, community pharmacists) from
a given country. It was felt, however, that what the survey lost in balance it gained in being random
and anonymous.
The first six questions of the survey were on the profile of the respondent asking, amongst others,
country of residence, current occupation (student, academic, community pharmacist), and, for students,
year of study.
Questions 7 through 19 asked about 13 clusters of competences with a total of 68 competences.
Questions in clusters 7 through 11 were concerned with personal competences and in clusters 12
through 19 with patient care competences (Table A1).
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Respondents were asked to rank the proposals for competences with a 4-point Likert
scale (Table 2).
Table 2. Ranking of competences.
Rank Significance Explanation
1 Not important Can be ignored
2 Quite important Valuable but not obligatory
3 Very important Obligatory, with exceptions depending upon field of pharmacy practice
4 Essential Obligatory
There was also a “cannot rank” possibility as well as the possibility of leaving the answer blank;
these numbers were pooled.
Results are presented in the form of “scores”: score = (frequency rank 3 + frequency rank 4) as %
of total frequency. This calculation is based on that used by the MEDINE consortium [11] that studied
the ranking of competences for medical practice by academics and medical students. Scores were used
for descriptive purposes only.
Leik ordinal consensus, an indication of the ordinal dispersion characterization of the intra-group
frequencies [12] was calculated using an in-house excel spreadsheet. Responses for Leik ordinal
consensus were graded as they were in the MEDINE study:
‚ < 0.2 poor,
‚ 0.21 – 0.4 fair,
‚ 0.41 – 0.6 moderate,
‚ 0.61 – 0.8 substantial,
‚ > 0.81 good.
Data for the three groups were analyzed at three levels: overall, cluster of competences, and
individual competences. Data comparing first and fifth year students were analyzed at the competence
level. Data comparing scores from five countries with an arbitrarily chosen number of respondents
ě 20 (see Table 1), with the nature or the content of the pharmacy course was also analyzed at the
competence level only. The nature of the course was defined on the basis of the hours spent on
medicinal and chemical sciences [13] and given as an index “medicinal/chemical score” = (% of
total course hours spent on medicinal subjects /% of total course hours spent on chemical subjects).
Medicinal subjects included pharmacology, therapeutics, etc., and chemical subjects included analytical
chemistry, organic chemistry, etc. The full list of subjects in each is given in the paper on heterogeneity
on pharmacy education in Europe cited previously. Data were also compared to the course content:
the relative amounts of time spent on lectures and on traineeship (data from the PHARMINE study).
The significance of differences between the results for ranking by groups was established using
the chi-square test on the distribution of frequencies for the four ranks. A significance level of p < 0.05
was used (chi-square for three degrees of freedom (4 ranks ´ 1) = 7.81; ns = not significant).
Data is presented mainly as star plots. Star plots are suited to display multivariate ordinal
observations with an arbitrary number of variables. This representation is suitable for the study of
clusters as well as for detecting outliers [14].
All statistical tests were performed using GraphPad software [15].
3. Results and Discussion
The first level of analysis was the overall analysis of the pooled results (n = 68 competences). In
Table 3 is given the distribution of rankings. For all three groups the response rate was high with
only 6.9% to 11.7% unable to reply. This suggests that all groups of respondents considered they were
sufficiently informed to reply to the questions asked.
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Table 3. Overall distribution (over 68 competences) of rankings by students, community pharmacists,
and academics.
Students CommunityPharmacists Academics
Number of
respondents 370 258 241
Theoretical total
number of replies 25,160 (= 370 ˆ 68) 17,544 (= 258 ˆ 68) 16,388 (= 241 ˆ 68)
Replies by rank Frequency % Frequency % Frequency %
4 8428 33.5 6643 37.9 5821 35.5
3 8967 35.6 6002 34.2 6005 36.6
2 4278 17.0 3076 17.5 2982 18.2
1 531 2.1 608 3.5 366 2.2
Cannot rank + blanks 619 11.7 1215 6.9 1214 7.4
Score (%) 77.4 78.3 77.9
Leik ordinal
consensus 0.59 0.55 0.58
Scores for the three groups were similar and within the range of means of 77.4% to 78.3% showing
that almost 80% of the competences proposed were considered “obligatory for practice” by all.
Values for Leik’s ordinal consensus were similar (0.55–0.59) and at the top end of the “moderate”
grade (0.41–0.6). It should be noted, however, that this particular Leik analysis confounds groups
and competences. Thus ordinal consensus may be moderate because there are differences amongst
the groups and/or amongst the competences. Albeit as judged from the Leik ordinal consensus
values, dispersion was relatively low. This suggests that groups were relatively homogeneous and
there were no subgroups with responses significantly different from the others. Similar values for
ordinal consensus were reported by the MEDINE consortium when they evaluated the ranking of
competences for medical doctors. Their respondent population consisted of two-thirds academics
delivering undergraduate medical education, and 28% medical students (see MEDINE citations above).
The second level of analysis was based on the grouping of competences into clusters representing
the major domains of practice. In Figure 1 are given the scores for the 13 clusters of competences
(numbered 7 through 19).
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Figure 1. Scores (central vertical axe, 0%–100%) for the 13 (numbered 7 through 19) clusters of
competences of students (full line), academics (dashed line), and community pharmacists (dotted line).
Scores for most clusters were 80% or above. Scores were lower than 80% for clusters of personal
competences especially those for cluster 11 that dealt with industrial pharmacy. In this case, students
had similar scores to academics (chi-square: 2.85, ns) and scored well above community pharmacists
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(chi-square: 89.04, p < 0.05). Students scored lower than academics for personal competence clusters
7 and 8, and lower than community pharmacists for cluster 8. Scores were also lower for cluster 19
(evaluation of outcomes) with no difference between students and academics (chi-square: 1.79, ns) or
community pharmacists (chi-square: 3.19, ns).
In Figure 2 are given the values for Leik’s ordinal consensus for the 13 clusters of competences
(numbered 7 through 19).
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For most clusters, ordinal consensus was at the top end of the 0.41–0.60 “moderate” category.
Students (and academics) generally s owed higher values than community pharmacists and this was
especially true for cluster 11 which community p armacist scored low (Figure 1) and showed a low
ordinal consensus (Figure 2). This suggests that the low score for cluster 11 was not shared by all
community pharmacists.
The third level of analysis was at the level of competences. In Figure 3 are given the scores for the
68 competences (numbered 1 through 68 on the circumference). This figure shows that more detail
amongst the groups is revealed by analysis at this third, competence level.
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Significant differences between students and community pharmacists (Table A1) were seen
in cluster 8 “personal competences 8–12: values” covering aspects such as contact, confidentiality,
responsibility and ethics for which student scores were lower than those of community pharmacists.
Pharmacy 2016, 4, 8 7 of 16
This was also seen but to lesser extent in the comparison between students and academics. Student
scores for quality aspects of drug production and testing were higher than those of community
pharmacists—cluster 11 (industrial pharmacy, competences 38–42) and competence 57 in cluster 15
“ability to manufacture medicinal products that are not commercially available”. It may be worthwhile
in the future to consider focus groups in order to ascertain when and why do community pharmacists
change their perspective on those competences (38–42) related to industrial pharmacy. Differences
between students and academics were seen in cluster 7 “personal competences 1–7: learning and
knowledge”; competences 1, 3, and 4 dealing with ability to learn independently and critical appraisal
of relevant knowledge were scored lower by students.
Although competence 6 dealing with research issues was scored low by students (and by
academics) the score was significantly higher than that of community pharmacists. This lack of
recognition that pharmacy is a research-based discipline is paralleled by the lack of a substantial
link between biomedical research and medical education and practice as described in the MEDINE
study [16]. In the latter paper, Van Schravendijk and his MEDINE colleagues suggested ways of
strengthening this link by bibliographic research and thesis work during pre-graduate study.
Such tools do exist in many pharmacy departments. In some cases this “science” aspect is taken
even further with traineeships based on participation in clinical research topics in community and
hospital pharmacy, and in pharmaceutical research and development in industrial settings. Further
efforts are needed to promote such activities at a wider postgraduate level. Emphasis on such aspects
in continuing professional development could help maintain the research-based nature of pharmacy.
Globally, the ranking by students, academics, and community pharmacists were similar. Patient
care competences were ranked similarly by students and community pharmacists suggesting,
importantly, that students have a good conception of their future job responsibilities and practice.
Because there were few differences between academics and community pharmacists, it is also important
to notice that academics have a good conception of the activity in community pharmacy. This critical
nature of the “type of patient care provided by pharmacists” has been emphasized following evaluation
of competences for pharmacists on a world-wide basis [17].
In Figure 4 are given the values for Leik’s ordinal consensus for the 13 clusters of competences
(numbered 7 through 19).
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For many competences ordinal consensus was lower in community pharmacists than in both
students and academics. Ordinal consensus was low for all groups for “competences” 24 “biology”
and 25 “physics”. These are, however, “subjects” not “competences”.
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Figure 5 shows the ranking scores for first (n = 30) and fifth (n = 77) students. Competences 24, 25,
26, 35, 36, 38, and 43 decreased in ranking from the first to the fifth year, whereas 4, 22, 31, 37, 39, 59,
63, and 65 increased.
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Although the overall patterns of the rankings showed no large discrepancies amongst the different
countries, there were significant differences in the mean scores (Table 4) with the Czech Republic
giving the lowest score (73%) and Romania the highest (84%).
Table 4. Mean scores for five countries shown in Figure 6 together with data for course nature
(= time spent on traineeship/time spent on lectures) and course content (= time spent on medicinal
subjects/time spent on chemical subjects). Data from Atkinson (2014) and PHARMINE (2014)
cited previously.
Country
Mean Ranking
Score (%, n = 68
Competences)
Course Nature Course Content
Time Spent on
Traineeship/Time Spent
on Lectures
Time Spent on Medicinal
Subjects/Time Spent on
Chemical Subjects
Belgium 80 0.75 1.13
Czech Republic 73 0.76 1.12
Germany 78 1.25 0.71
Portugal 83 0.84 1.64
Romania 84 0.66 0.95
Although there are substantial differences in course nature and content this was not reflected in
mean scores (Table 3) or in the patterns of the rankings (Figure 6). Some differences were observed:
for example, students of the Czech Republic gave low scores for competence 18 (ability to design
and manage the development processes in the production of medicines) and competence 40 (current
knowledge of European directives on qualified persons (QPs)), but this was not observed for Belgium
which has a similar course nature and content.
4. Conclusions
To our knowledge, this is the first study in which students in a sectoral profession are asked to
rank the relative importance of competences for practice in their future professional lives. Globally,
their perception of the relative importance of competences is similar to that of practicing community
pharmacists especially in the area of patient care competences.
Given the growing interest in competence-based educational reforms in several areas of the world,
it would be useful to do studies similar to this one in various areas worldwide in order to see whether
student perceptions are equally advanced in all areas. This could be done through European-funded
programs such as Erasmus+ [18] and would be one way of increasing awareness of and developing
competence-based education in other regions. The results of such studies could be linked to the
education framework used to train future pharmacists in those countries.
A proviso to this study is that it concentrates on community pharmacy practice. Whilst 70%–80%
of pharmacists work in a community pharmacy in Europe (data from PHARMINE), many work in
other areas such as hospital and industrial pharmacy. As education for jobs in the latter areas differs
substantially amongst European countries, and the options for hospital and industrial pharmacy
courses and training occur late in the courses it proved impossible to do a study similar to this in the
specific areas of hospital or industrial pharmacy.
Another proviso is that, given the diversity of country of origin, it would have been useful to
know something about the level of English proficiency for cohorts from different counties as the survey
was delivered in English and if proficiency in English had any impact on the results. It would have
been interesting to have information on the English proficiency, via for example, scores in the “Test of
English as a Foreign Language (TOEFL)” examination [19]. However this is not uniformly applied in
Europe and not even uniformly applied within each member state. We can comment that students
ranked competence 21 “ability to communicate in English” very highly (score 85) suggesting that they
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at least recognized the necessity to understand English. It should be noted that the consortium strived
to make the questions understandable to non-native English speakers.
Furthermore, when asked to rank subject areas listed in the European Directive many were
ranked as “not important/can be ignored”. These are not competences [20] as such but components of
competences (see Miller’s triangle, below). They were included in the questionnaire because they are
cited in the European directive on the sectoral profession of pharmacy [21].
The final question to be discussed relates to how a competence framework could be incorporated
into pharmacy education. This will be discussed in relation to Miller’s triangle that describes a
conceptual, pyramidal model of the various facets of competence, in his case applied to clinical
practice [22] (Figure 7).
The studies cited in the introduction on the use of competency frameworks for the improvement
of performance are mostly concerned with the fourth level of this triangle—“does/action” whereas in
this paper we are equally concerned with the other three levels, especially the first two “knows and
knows how”. Given the low scores of most of the subject areas included in cluster 10, it would appear
that students (as well as academics and community pharmacist practitioners) do not fully grasp the
importance of some subjects as building blocks of the competences required for practice. This also
outlines the fact that the simple inclusion of subject areas within a European regulatory directive is
not a fully sufficient way to ensure the teaching and acquirement of competences for practice. One
of the functions or uses of the PHAR-QA framework could be therefore to provide a road-book for
the development of integrated, coordinated courses that groups several subject areas under a broad
competence heading. The way in which this is to be carried out need not be harmonized or imposed by
European directives or other legislative means but could be left to the wisdom of individual faculties
to find solutions. Another function of the PHAR-QA competence framework could be as a basis of
accreditation at level 2 of the Miller’s triangle allowing a more realistic evaluation of a student based
on his/her competence to synthesise the different subject areas into a comprehensive understanding
of different competences. This entails a switch in evaluation from normative procedures that rank
candidates with arbitrary cut-off points to competence-referenced testing that evaluates whether a
candidate is (or is not) ready to pass onto a higher level. The way in which this is developed would
again be up to individual faculties. It should be noted that changing the method of evaluation is often
a good beginning for a change in courses.
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The PHAR-QA framework could also be used at the third level in the performance testing of
students. Here one could also use the patient substitutes (or “standardized” patients as described by
Miller cited previously). Such “patients” would present students with elements such as symptoms,
prescriptions, etc. calling upon their competences to solve problems related to drug interactions, for
example. How this would be constructed and run would again by up to the individual faculty. It
should also be noticed that a change to a competency-based assessment would logically abandon
a fixed time traineeship ship at level 3, as is specified by the EU directive and adopted by all EU
countries at the present time, and its replacement by a system whereby the student would remain at
level 3 in traineeship until s/he has shown to be competent enough to pass to level 1 and exercise
his/her profession [23]. Whilst not going to such an extreme, it can be acknowledged that there is a
(sometimes large) gap between levels 1 through 3 and level 4 or between the more theoretical academic
approach and the real-life work situation. This could be addressed in junior pharmacists using the
PHAR-QA framework as a basis for work-based self-directed learning and case-based assignments set
and monitored by a senior colleague (see the Rutter, et al. reference cited in the introduction).
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Appendix
Table A1. Ranking scores for competences by groups (students, academics, community pharmacists).
Note that the numbering of the clusters of competences starts at 7, i.e., after the 6 questions on profile
of respondent). N: number of competence. Stud.: students. Acad.: academics. Comm.: community
pharmacists. Chi: chi-square. vs.: versus.
N Competence Stud. Acad. Chi Stud.vs. Acad. Comm.
Chi Stud.
vs. Comm.
Cluster 7.
Personal
competences:
learning and
knowledge.
1
Ability to identify learning needs
and to learn independently
(including continuous professional
development (CPD)).
84.5 93.7 15.7 89.8 13.1
2
Analysis: ability to apply logic to
problem solving, evaluating pros
and cons and following up on the
solution found.
88.8 94.5 7.5 91.1 3.6
3
Synthesis: capacity to gather and
critically appraise relevant
knowledge and to summarise the
key points.
85.1 92.8 10.8 87.9 4.0
4
Capacity to evaluate scientific data
in line with current scientific and
technological knowledge.
76.5 87.3 18.5 75.8 0.4
5
Ability to interpret preclinical and
clinical evidence-based medical
science and apply the knowledge
to pharmaceutical practice.
86.0 81.2 5.2 75.9 17.3
6
Ability to design and conduct
research using appropriate
methodology.
60.6 65.4 4.9 40.2 34.3
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Table A1. Cont.
N Competence Stud. Acad. Chi Stud.vs. Acad. Comm.
Chi Stud.
vs. Comm.
7
Ability to maintain current
knowledge of relevant legislation
and codes of pharmacy practice.
81.7 86.3 3.3 91.7 25.7
Cluster 8.
Personal
competences:
values.
8 Demonstrate a professional approachto tasks and human relations. 86.6 91.5 7.7 94.5 23.3
9 Demonstrate the ability to maintainconfidentiality. 85.4 92.3 22.8 95.3 50.6
10
Take full personal responsibility for
patient care and other aspects of
one’s practice.
84.4 88.3 3.2 94.8 24.9
11 Inspire the confidence of others inone’s actions and advice. 77.8 83.8 8.9 88.8 13.0
12 Demonstrate high ethical standards. 85.3 95.3 43.4 95.2 24.6
Cluster 9.
Personal
competences:
communication
and
organisational
skills.
13 Effective communication skills (bothorally and written). 91.2 93.5 3.9 94.8 4.0
14 Effective use of informationtechnology. 81.1 83.8 1.4 86.1 3.8
15 Ability to work effectively as part ofa tea. 86.4 83.3 6.1 89.2 1.1
16
Ability to identify and implement
legal and professional requirements
relating to employment (e.g., for
pharmacy technicians) and to safety
in the workplace.
74.8 77.9 1.9 81.0 4.5
17 Ability to contribute to the learningand training of staff. 73.5 79.6 6.6 82.5 6.6
18
Ability to design and manage the
development processes in the
production of medicines.
61.2 60.0 0.8 43.2 38.0
19 Ability to identify and manage riskand quality of service issues. 77.5 76.1 4.0 79.2 2.3
20 Ability to identify the need fornew services. 65.0 61.8 7.7 64.5 1.2
21 Ability to communicate in Englishand/or locally relevant languages. 84.5 79.6 2.3 74.1 16.3
22 Ability to evaluate issues related toquality of service. 73.0 71.0 3.5 77.9 7.4
23
Ability to negotiate, understand a
business environment and develop
entrepreneurship.
62.2 46.4 15.6 64.1 2.0
Cluster 10.
Personal
competences:
knowledge of
different areas
of the science
of medicines.
24 Plant and animal biology. 38.8 31.1 5.1 39.3 1.0
25 Physics. 20.9 25.6 2.3 21.7 0.8
26 General and inorganic chemistry 53.0 45.6 3.3 43.9 5.3
27 Organic andmedicinal/pharmaceutical chemistry. 86.3 80.2 10.8 66.0 37.0
28 Analytical chemistry 65.8 60.0 3.0 41.9 46.9
29 General and applied biochemistry(medicinal and clinical). 85.4 74.2 10.8 68.8 22.6
30 Anatomy and physiology;medical terminology. 85.2 75.8 11.2 88.7 3.3
31 Microbiology. 72.2 67.0 3.3 72.2 1.5
32 Pharmacology includingpharmacokinetics. 97.5 95.6 3.7 94.7 3.0
33 Pharmacotherapy andpharmaco-epidemiology. 95.3 92.5 3.1 94.3 2.2
34 Pharmaceutical technology includinganalyses of medicinal products. 86.9 89.0 1.4 62.0 50.8
35 Toxicology. 85.0 84.4 17.3 74.0 27.7
36 Pharmacognosy. 65.9 52.9 11.3 66.5 2.1
37 Legislation and professional ethics. 71.7 88.8 26.8 89.5 44.2
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Table A1. Cont.
N Competence Stud. Acad. Chi Stud.vs. Acad. Comm.
Chi Stud.
vs. Comm.
Cluster 11.
Personal
competences:
understanding
of industrial
pharmacy.
38
Current knowledge of design,
synthesis, isolation, characterisation
and biological evaluation of
active substances.
59.9 57.5 1.9 41.7 34.2
39
Current knowledge of good
manufacturing practice (GMP) and of
good laboratory practice (GLP).
79.2 75.4 1.6 59.4 29.8
40 Current knowledge of Europeandirectives on qualified persons (QPs). 55.3 59.2 1.8 43.7 39.9
41 Current knowledge of drugregistration, licensing and marketing. 65.7 72.1 4.6 55.7 11.9
42 Current knowledge of good clinicalpractice (GCP). 78.1 68.2 9.1 64.5 23.8
Cluster 12.
Patient care
competences:
patient
consultation
and
assessment.
43 Ability to perform and interpretmedical laboratory tests. 72.0 65.3 5.9 65.5 6.0
44
Ability to perform appropriate
diagnostic or physiological tests to
inform clinical decision making e.g.,
measurement of blood pressure.
76.1 64.5 17.3 73.6 7.8
45
Ability to recognise when referral to
another member of the healthcare
team is needed because a potential
clinical problem is identified
(pharmaceutical, medical,
psychological or social).
91.7 89.1 2.2 91.7 9.5
Cluster 13.
Patient care
competences:
need for drug
treatment.
46
Retrieval and interpretation of
relevant information on the patient’s
clinical background.
85.6 79.3 8.4 84.0 0.7
47
Retrieval and interpretation of an
accurate and comprehensive drug
history if and when required.
87.6 89.4 5.1 91.5 2.3
48
Identification of non-adherence and
implementation of appropriate
patient intervention.
87.1 85.8 6.1 86.8 24.5
49
Ability to advise to physicians
and—in some cases—prescribe
medication.
81.9 80.7 2.5 87.6 5.3
Cluster 14.
Patient care
competences:
drug
interactions.
50
Identification, understanding and
prioritisation of drug-drug
interactions at a molecular level
(e.g., use of codeine
with paracetamol).
91.4 91.8 1.1 91.6 0.6
51
Identification, understanding, and
prioritisation of drug-patient
interactions, including those that
preclude or require the use of a
specific drug (e.g., trastuzumab for
treatment of breast cancer in women
with HER2 overexpression).
91.4 87.7 4.4 89.7 5.0
52
Identification, understanding, and
prioritisation of drug-disease
interactions (e.g., NSAIDs in
heart failure).
97.0 94.5 8.9 96.6 2.7
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Table A1. Cont.
N Competence Stud. Acad. Chi Stud.vs. Acad. Comm.
Chi Stud.
vs. Comm.
Cluster 15. Patient
care competences:
provision of drug
product.
53
Familiarity with the
bio-pharmaceutical,
pharmacodynamic and
pharmacokinetic activity of a
substance in the body.
89.3 90.8 3.5 81.2 11.6
54
Supply of appropriate medicines
taking into account dose, correct
formulation, concentration,
administration route and timing.
94.3 96.3 16.3 94.9 18.0
55
Critical evaluation of the
prescription to ensure that it is
clinically appropriate and legal.
93.9 94.1 6.6 94.0 11.1
56
Familiarity with the supply chain
of medicines and the ability to
ensure timely flow of drug
products to the patient.
81.6 78.6 4.5 84.6 11.3
57
Ability to manufacture medicinal
products that are not commercially
available.
74.1 69.0 1.5 60.5 21.2
Cluster 16. Patient
care competences:
patient education.
58
Promotion of public health in
collaboration with other actors in
the healthcare system.
75.8 75.1 1.1 82.6 5.9
59 Provision of appropriate lifestyleadvice on smoking, obesity, etc. 76.9 71.0 3.8 80.9 4.7
60
Provision of appropriate advice on
resistance to antibiotics and similar
public health issues.
90.3 89.4 5.2 93.1 3.6
Cluster 17. Patient
care competences:
provision of
information and
service.
61
Ability to use effective
consultations to identify the
patient’s need for information.
85.6 81.1 3.1 90.9 11.1
62
Provision of accurate and
appropriate information on
prescription medicines.
92.7 89.3 8.0 94.4 11.0
63
Provision of informed support for
patients in selection and use of
non-prescription medicines for
minor ailments
(e.g., cough remedies).
85.7 89.4 1.7 94.0 14.4
Cluster 18. Patient
care competences:
monitoring of
drug therapy.
64
Identification and prioritisation of
problems in the management of
medicines in a timely manner and
with sufficient efficacy to ensure
patient safety.
88.5 87.9 8.2 93.0 8.7
65
Ability to monitor and report to all
concerned in a timely manner, and
in accordance with current
regulatory guidelines on Good
Pharmacovigilance Practices
(GVPs), Adverse Drug Events and
Reactions (ADEs and ADRs).
79.8 80.9 5.0 83.4 3.3
66
Undertaking of a critical evaluation
of prescribed medicines to confirm
that current clinical guidelines are
appropriately applied.
80.7 81.6 0.3 80.6 4.5
Cluster 19. Patient
care competences:
evaluation of
outcomes.
67
Assessment of outcomes on the
monitoring of patient care and
follow-up interventions.
73.3 73.7 0.5 79.0 4.4
68 Evaluation of cost effectivenessof treatment. 53.3 57.7 2.1 61.2 4.8
Chi-square, d. f. 3, p = 0.05: 7.8. The chi-square test was performed on the frequencies of rankings.
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